Attenuation of the inflammatory response and cytokine production, reduction of oxidative stress, and correction of the fetal gene expression pattern characteristic of DCM were all results of GRK2 inhibition in cardiac tissue [59]. The gene discussed is GRK2; the disease is familial dilated cardiomyopathy.